BIO-IDENTICAL HORMONES MARKET ANALYSIS

Bio-Identical Hormones Market, By Product Type (Estrogen, Progesterone, and Testosterone), By Dosage Form (Tablets and Capsules, Creams and Gels, Injectable, Patches and Implants, and Others), By End User (Hospitals, Clinics, Academics and Research Institutes, and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Dec 2024
Code : CMI3293
Formats :
Excel and PDF
Industry : Biotechnology

Market Challenges And Opportunities

However, an increased risk of breast cancer in females opting for bio-identical hormone therapy is expected to restrain the market over the forecast period. For instance, according to a study published in The Lancet journal, September 2019, nearly 108,647 postmenopausal women developed breast cancer, from 1992 to 2018, among these approximately 55,575 females were using the hormonal therapy.